Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Atara Biotherapeutics Ownership Summary


Atara Biotherapeutics is owned by 14.79% institutional investors, 21.39% insiders, and 63.82% retail investors. Redmile group is the largest institutional shareholder, holding 3.62% of ATRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.

ATRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtara Biotherapeutics14.79%21.39%63.82%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group441.70K3.62%$3.41M
Vestal point capital, lp94.08K0.77%$726.34K
Staley capital advisers75.00K0.61%$579.00K
Blackrock funding, inc. /de70.85K0.58%$546.95K
Acadian asset management65.16K0.53%$502.00K
Marshall wace, llp42.35K0.35%$326.98K
Mackenzie financial22.51K0.18%$173.81K
Raymond james financial4.02K0.03%$31.04K
Jones financial companies lllp703.000.01%$5.60K
Birchview capital, lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group441.70K0.36%$3.41M
Vestal point capital, lp94.08K0.04%$726.34K
Staley capital advisers75.00K0.02%$579.00K
Acadian asset management65.16K0.00%$502.00K
Marshall wace, llp42.35K0.00%$326.98K
Mackenzie financial22.51K0.00%$173.81K
Birchview capital, lp---
Legal & general group---
Geode capital management---
Ecor1 capital---

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp42.35K0.00%42.35K
Mackenzie financial22.51K0.00%22.51K
Blackrock funding, inc. /de70.85K-10.05K
Raymond james financial4.02K-4.02K
Vestal point capital, lp94.08K0.04%-

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---10.17M
Blackrock---6.83M
Bank of america corp /de/---6.58M
Vanguard group---5.01M
Price t rowe associates inc /md/---4.96M

New Positions

HolderShares% AssetsChangeValue
Mackenzie financial22.51K0.00%22.51K$173.81K
Raymond james financial4.02K-4.02K$31.04K

Sold Out

HolderChange
Citigroup-2.00
Nelson, van denburg & campbell wealth management group-23.00
Eversource wealth advisors-35.00
Nisa investment advisors-50.00
Gamma investing-56.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202532-8.57%1,803,95019.18%147.48%11-8.33%6-53.85%
Mar 31, 202536-14.29%2,086,297-10.96%194.03%13-43.48%1318.18%
Dec 31, 20242100.00%6380.00%-360000.00%1---
Sep 30, 20241-80.00%35-99.98%-2.78%--100.00%--100.00%
Jun 30, 20245-93.98%182,077-99.78%-0.00%1-97.62%2-92.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF120.26K2.05%-
Vanguard Total Stock Mkt Idx Inv117.69K1.69%-2.57K
Vanguard Institutional Extnd Mkt Idx Tr49.27K0.71%-17.18K
Fidelity Extended Market Index29.13K0.43%-76.00
Fidelity VIP Disciplined Small Cap Init16.24K0.24%-1.00
Bridgeway Ultra-Small Company Market14.00K0.20%-
Fidelity Enhanced Small Cap ETF10.45K0.18%-
NT R2000 Value Index Fund - NL255.47K0.18%-
NT R2000 Index Fund - NL9.83K0.17%-1.01K
Fidelity Total Market Index10.59K0.16%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 18, 2025Nguyen AnhCo President and CEOSell$18.82K
Aug 18, 2025Nguyen AnhCo President and CEOSell$14.88K
Aug 18, 2025Nguyen AnhCo President and CEOSell$661.94
Aug 18, 2025Grant-Huerta Yanina Chief Accounting OfficerSell$638.50
Aug 18, 2025Grant-Huerta Yanina Chief Accounting OfficerSell$998.72

Insider Transactions Trends


DateBuySell
2025 Q326
2025 Q2-2
2025 Q1-3
2024 Q4-3
2024 Q3-12

ATRA Ownership FAQ


Who Owns Atara Biotherapeutics?

Atara Biotherapeutics shareholders are primarily institutional investors at 14.79%, followed by 21.39% insiders and 63.82% retail investors. The average institutional ownership in Atara Biotherapeutics's industry, Biotech Stocks , is 306.59%, which Atara Biotherapeutics falls below.

Who owns the most shares of Atara Biotherapeutics?

Atara Biotherapeutics’s largest shareholders are Redmile group (441.7K shares, 3.62%), Vestal point capital, lp (94.08K shares, 0.77%), and Staley capital advisers (75K shares, 0.61%). Together, they hold 5.01% of Atara Biotherapeutics’s total shares outstanding.

Does Blackrock own Atara Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Atara Biotherapeutics.

Who is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Redmile group is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.36% of its assets in 441.7K Atara Biotherapeutics shares, valued at 3.41M$.

Who is the top mutual fund holder of Atara Biotherapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atara Biotherapeutics shares, with 2.05% of its total shares outstanding invested in 120.26K Atara Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools